In a significant shift for youth healthcare in Colorado, two leading hospitals — Children's Hospital Colorado and Denver Health — have announced they will no longer provide gender-affirming medical treatments, such as puberty blockers and cross-sex hormones, to patients under 18. The decisions come in direct response to actions by the U.S. Department of Health and Human Services (HHS) under the Trump administration, which has threatened investigations and the loss of critical federal funding. This move highlights the ongoing national debate over access to such care, balancing concerns about patient safety, medical evidence, and federal oversight.
 |
| Vitaly Gariev/Unsplash |
The Announcements
Children's Hospital Colorado, one of the state's primary providers of pediatric care, stated that it is suspending all medical gender-affirming treatments for minors while awaiting federal court rulings and monitoring the evolving legal situation. The hospital emphasized that an HHS referral for investigation puts its Medicare and Medicaid funding at risk — funding that supports care for hundreds of thousands of children unrelated to gender issues.
Denver Health echoed similar concerns, describing the decision as "difficult" but necessary after reviewing recent HHS actions. Both institutions stressed that the changes disrupt established doctor-patient relationships and limit access to services that some families and providers view as essential.
Importantly, neither hospital has ever performed gender-affirming surgeries on minors, and they will continue to offer supportive services, such as counseling, to affected families.
The Hubert H. Humphrey Building, headquarters of the U.S. Department of Health and Human Services
Federal Context and Recent Developments
The suspensions follow a series of aggressive steps by the Trump administration's HHS. In December 2025, the department proposed new rules that would prohibit hospitals receiving Medicare and Medicaid funds from providing certain gender-affirming treatments to minors, framing them as experimental and potentially harmful. Secretary Robert F. Kennedy Jr. has publicly described such care as causing "lasting damage" to vulnerable youth.
Latest update: As of late December 2025, more than 18 states and the District of Columbia have filed lawsuits challenging these HHS measures, arguing they infringe on state authority and access to medically recognized care. Legal battles are ongoing in multiple federal courts. Source: Maryland Matters
The Broader Debate
The issue remains deeply divisive. Major medical organizations, including the American Academy of Pediatrics and the Endocrine Society, support gender-affirming care as evidence-based and potentially life-saving for transgender youth experiencing gender dysphoria. Critics, including some policymakers and parent groups, argue that the long-term effects of puberty blockers and hormones are insufficiently studied in minors and that such interventions should be restricted until adulthood.
While over 20 states have enacted bans or severe restrictions on this care, others like Colorado have historically protected access. The federal pressure now appears to be influencing even progressive states' providers.
Images reflecting different perspectives in the national conversation on youth gender healthcare
Looking Ahead
Families affected by these changes face uncertainty as court challenges play out. Hospitals have pledged to monitor developments closely and resume services if the legal landscape allows. In the meantime, the decisions underscore how federal funding leverage can reshape healthcare delivery at the state level.